www.neuronatherapeutics.comHealthcare / BioTech & PharmaFounded: 2008Funding to Date: $481.17MM
Neurona Therapeutics is a company that strives to develop clinical-stage biotherapeutic treatments for neurological disorders with a focus on advancing regenerative cell therapy candidates. The company researches allogeneic therapies that come from stem cells harvested from donors. Neurona's proprietary therapy NRTX-1001 aims to reverse the effects of Alzheimer’s disease and other nervous system disorders. Neurona Therapeutics was founded by Arnold Kriegstein and Cory R. Nicholasin in 2008 and is headquartered in San Francisco, CA.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
02/08/2024 | Series E | $120MM | $xx.xx | $399.51MM | Viking Global Investors, Cormorant Asset Management, The Column Group, LYFE Capital, Schroders Capital, Willett Advisors, Ysios Capital Partners, Euclidean Capital, SymBiosis, Alexandria Venture Investments, Berkeley Frontier Fund, Sphera Biotech, Spur Capital Partners, UCB Ventures, UC Investments | |
Price per Share
$xx.xx
Shares Outstanding
66,666,652
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
800.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Viking Global Investors, Cormorant Asset Management, The Column Group, LYFE Capital, Schroders Capital, Willett Advisors, Ysios Capital Partners, Euclidean Capital, SymBiosis, Alexandria Venture Investments, Berkeley Frontier Fund, Sphera Biotech, Spur Capital Partners, UCB Ventures, UC Investments
|
||||||
03/19/2021 | Series D | $72.01MM | $xx.xx | $248.51MM | UCB Ventures, The Column Group, Sphera Fund Management, Alexandria Venture Investments, Ironfire Ventures | |
Price per Share
$xx.xx
Shares Outstanding
40,004,768
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
800.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
UCB Ventures, The Column Group, Sphera Fund Management, Alexandria Venture Investments, Ironfire Ventures
|
||||||
11/18/2019 | Series C | $15.03MM | $xx.xx | $154.19MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
8,350,160
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
800.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Undisclosed Investors
|
||||||
02/08/2018 | Series B | $10.04MM | $xx.xx | $103.44MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
8,370,274
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
800.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Undisclosed Investors
|
||||||
12/01/2015 | Series A | $23.5MM | $xx.xx | $78.33MM | The Column Group, Alexsis de Raadt-St. James | |
Price per Share
$xx.xx
Shares Outstanding
26,111,111
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
800.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
The Column Group, Alexsis de Raadt-St. James
|